On 25 February, the European Parliament adopted the proposal to amend the Biocidal Products Regulation (BPR). The amendment clarifies some ambiguous terms and errors which were identified not long after the Regulation was adopted in 2012. The Biocidal Products Regulation came into force on 1 September 2013.
Amongst the new amendments to the BPR, please see below the most relevant:
- Clarification on the use of biocidal products as processing aids will be included.
- The scope of the biocidal product family concept has been broadened to include products with a lower hazard classification if they have similar composition, exposure levels and proven efficacy.The original text only allowed for products with the same classification to be in the same family. The new proposal provides more flexibility to create family dossiers, resulting in reduced authorisation fees and less administrative burdens for companies as well as room for innovation of the products.
- The correction of the unintended market freeze on new treated articles containing active substances that have not been through the review programme yet as the process is on-going.
- The limits required to be established in accordance with the Food Contact Materials (FMC) Regulation are specific migration limits or limits for the residual content in FCM.
- The list of alternative suppliers has been amended to provide the possibility for product manufacturers to support an active substance dossier where it can provide all necessary data.
- To ensure consistency between BPR and CLP, specific target organ toxicity by single or repeated exposure category 1 as a classification criterion will be amended in order to preclude authorisation for the general public use.
- Finally, ECHA will play a new enforcement role in ensuring exchange of information between Member States, provide support and assistance. This is a positive development towards harmonisation of the internal market.
The text of the new Regulation will be published in the EU’s Official Journal before entering into force. It is expected for 2025.
For further information about our services on Biocidal Products, please do not hesitate to contact one of our advisors or visit our website via the following link:
https://kaeltia.com/en/
